Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)
Tramadol Hydrochloride
Product Images NDC 45865-976
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)
This appears to be a chart showing the concentration of Tramadol at different time intervals (in hours) for two different types of medication: Tramadol Hydrochloride Extended-Release Tablets (at a dosage of 200 mg per day) and Tramadol Hydrochloride Tablets (at a dosage of 50 mg every 6 hours). The Tramadol concentration (in ng/mL) is represented on the y-axis.*
Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)
This is a chart showing the concentration of M1 (a metabolite of tramadol) in ng/mL over time (in hours) for two different medications - Tramadol Hydrochloride Extended-Release Tablets (dosed at 200mg once daily) and Tramadol Hydrochloride Tablets (dosed at 50mg every 6 hours).*
Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)
This is a graph representing the percentage of patients who achieved different levels of pain relief after taking Tramadol Hydrochloride Extended-Release Tablets in a WOMAC Pain Responder Analysis study. The study had four variations of the tablets, 100mg, 200mg, 300mg, and 400mg. The results were compared to a placebo, represented by the bottom bar of the graph. The x-axis shows the response threshold, which is the percentage improvement from baseline. The graph has a bell curve shape, showing that the most significant number of patients improved their pain levels between 20% and 60% with the medication.*
Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)
This is a chart that shows the results of a study (Study 015) evaluating the effectiveness of Tramadol Hydrochloride Extended-Release Tablets on treating arthritis pain. The chart displays the percentage of patients who achieved a response to the drug at various levels of pain intensity. The drug is compared to a placebo control, represented by the empty space next to the drug graph. The x-axis shows the response threshold, indicating the percentage improvement from the patient's initial baseline pain measurement. The highest response rate is at 50% improvement, where almost 80% of patients showed a positive response to the drug.*
Pdp (976)
This text appears to be a prescription label for Tramadol HCL ER tablets with a strength of 200mg. The label also includes a warning to avoid alcohol and drowsiness while taking the medication. Unfortunately, due to the poor quality of , some of the text is difficult to read and some characters are non-English.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
